The histogenesis of several compartments in the mammalian central nervous system (CNS) entails orchestrated series of neuronal migration. In particular, the cerebral cortex and cerebellum contain different classes of neurons organized in a laminated manner that is the product of coordinated neuronal migration. Genetic studies in humans and mice reveal the importance of several gene products that are necessary for the intact cytoarchitecture of the cortex and cerebellum. For instance, mice lacking Cdk5 display an inverted layering of the cortex and cerebellar hypoplasia indicating that Cdk5 is indispensable for neurodevelopment. Cdk5 is a small serine/threonine kinase that requires association with a regulatory subunit for kinase activation. Two neuronal specific activators of Cdk5 have been isolated, specifically p35 and p39. This proposal will test the hypothesis that p35 and p39 are the essential activators of Cdk5 during neurodevelopment. Thus, a mouse strain with targeted deletion of both p35 and p39 loci will be created These animals will also be utilized to delineate the function of p35 versus p39 in neurodevelopment. Recently, a role of Cdk5 in neurodegeneration is reported. In AD brains, p35 is proteolytically cleaved to generated a truncated 25 kDA fragment (p25). The p25/Cdk5 kinase can induce tau hyperphosphorylation, cytoskeleton collapse and neuronal death. We will test whether p35 to p25 conversion is downstream from neurotoxic processes pertinent to neurodegenerative disease and identify the protease that is responsible for p35 cleavage in vivo. Furthermore, we will determine if p35 to p25 conversion is an important event for neurodegeneration. The proposed experiments will shed light on the regulation of Cdk5 in neurodevelopment and neurodegeneration.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM053049-06
Application #
6286656
Study Section
Special Emphasis Panel (ZRG1-MDCN-1 (02))
Program Officer
Hagan, Ann A
Project Start
1996-04-01
Project End
2005-03-31
Budget Start
2001-04-01
Budget End
2002-03-31
Support Year
6
Fiscal Year
2001
Total Cost
$301,000
Indirect Cost
Name
Harvard University
Department
Pathology
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Su, Susan C; Rudenko, Andrii; Cho, Sukhee et al. (2013) Forebrain-specific deletion of Cdk5 in pyramidal neurons results in mania-like behavior and cognitive impairment. Neurobiol Learn Mem 105:54-62
Rudenko, Andrii; Dawlaty, Meelad M; Seo, Jinsoo et al. (2013) Tet1 is critical for neuronal activity-regulated gene expression and memory extinction. Neuron 79:1109-1122
Su, Susan C; Seo, Jinsoo; Pan, Jen Q et al. (2012) Regulation of N-type voltage-gated calcium channels and presynaptic function by cyclin-dependent kinase 5. Neuron 75:675-87
Patzke, Holger; Maddineni, Upendra; Ayala, Ramses et al. (2003) Partial rescue of the p35-/- brain phenotype by low expression of a neuronal-specific enolase p25 transgene. J Neurosci 23:2769-78
Patzke, Holger; Tsai, Li-Huei (2002) Calpain-mediated cleavage of the cyclin-dependent kinase-5 activator p39 to p29. J Biol Chem 277:8054-60
Ko, J; Humbert, S; Bronson, R T et al. (2001) p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J Neurosci 21:6758-71
Humbert, S; Lanier, L M; Tsai, L H (2000) Synaptic localization of p39, a neuronal activator of cdk5. Neuroreport 11:2213-6
Humbert, S; Dhavan, R; Tsai, L (2000) p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton. J Cell Sci 113 ( Pt 6):975-83
Kwon, Y T; Tsai, L H; Crandall, J E (1999) Callosal axon guidance defects in p35(-/-) mice. J Comp Neurol 415:218-29
Kwon, Y T; Tsai, L H (1998) A novel disruption of cortical development in p35(-/-) mice distinct from reeler. J Comp Neurol 395:510-22

Showing the most recent 10 out of 13 publications